Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 23 December 1988:
Vol. 242. no. 4886, pp. 1700 - 1702
DOI: 10.1126/science.2904702

Articles

Science, Vol 242, Issue 4886, 1700-1702
Copyright © 1988 by American Association for the Advancement of Science


articles

Repair of the secretion defect in the Z form of alpha 1-antitrypsin by addition of a second mutation

M Brantly, M Courtney, and RG Crystal

Pulmonary Branch, National Heart, Lung, and Blood Institute, Bethesda, MD.

Homozygous inheritance of the Z-type mutant form of the alpha 1-antitrypsin (alpha 1AT) gene results in the most common form of alpha 1AT deficiency, a human hereditary disease associated with a high risk for the development of emphysema and an increased incidence of neonatal hepatitis. The alpha 1AT-synthesizing cells of individuals with the Z gene have normal alpha 1AT messenger RNA levels, but alpha 1AT secretion is markedly reduced secondary to accumulation of newly synthesized alpha 1AT in the rough endoplasmic reticulum. Crystallographic analysis of alpha 1AT predicts that in normal alpha 1AT, a negatively charged Glu342 is adjacent to positively charged Lys290. Thus the Glu342----Lys342 Z mutation caused the loss of a normal salt bridge, resulting in the intracellular aggregation of the Z molecule. The prediction was made that a second mutation in the alpha 1AT genet that changed the positively charged Lys290 to a negatively charged Glu290 would correct the secretion defect. When the second mutation was added to the Z-type complementary DNA, the resulting gene directed the synthesis and secretion of amounts of alpha 1AT similar to that directed by the normal alpha 1AT complementary DNA in an in vitro eukaryotic expression system. This suggests the possibility that a human hereditary disease can be corrected by inserting an additional mutation in the same gene.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
ADD66, a Gene Involved in the Endoplasmic Reticulum-associated Degradation of {alpha}-1-Antitrypsin-Z in Yeast, Facilitates Proteasome Activity and Assembly.
C. M. Scott, K. B. Kruse, B. Z. Schmidt, D. H. Perlmutter, A. A. McCracken, and J. L. Brodsky (2007)
Mol. Biol. Cell 18, 3776-3787
   Abstract »    Full Text »    PDF »
Mutants of Neuroserpin That Cause Dementia Accumulate as Polymers within the Endoplasmic Reticulum.
E. Miranda, K. Romisch, and D. A. Lomas (2004)
J. Biol. Chem. 279, 28283-28291
   Abstract »    Full Text »    PDF »
Progression of Atherosclerosis Is Associated With Variation in the {alpha}1-Antitrypsin Gene.
P. J. Talmud, S. Martin, G. Steiner, D. M. Flavell, D. B. Whitehouse, S. Nagl, R. Jackson, M.-R. Taskinen, M. H. Frick, M. S. Nieminen, et al. (2003)
Arterioscler. Thromb. Vasc. Biol. 23, 644-649
   Abstract »    Full Text »    PDF »
Alpha1-Antitrypsin Deficiency -- A Model for Conformational Diseases.
R. W. Carrell and D. A. Lomas (2002)
N. Engl. J. Med. 346, 45-53
   Full Text »    PDF »
Pulmonary Cell Biology.
R. J. MASON and R. G. CRYSTAL (1998)
Am. J. Respir. Crit. Care Med. 157, S72-S81
   Full Text »    PDF »
Infection of Endothelium With E1-E4+, but Not E1-E4-, Adenovirus Gene Transfer Vectors Enhances Leukocyte Adhesion and Migration by Modulation of ICAM-1, VCAM-1, CD34, and Chemokine Expression.
S. Rafii, S. Dias, S. Meeus, K. Hattori, R. Ramachandran, F. Feuerback, S. Worgall, N. R. Hackett, and R. G. Crystal (2001)
Circ. Res. 88, 903-910
   Abstract »    Full Text »    PDF »



ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)